Aurinia Pharmaceuticals Inc. company logo
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH) EBITDA

Annual EBITDA

$33.52M$105.18M+146.77%

Summary

Current Value
As of today, AUPH annual EBITDA is $33.52M, up +146.77% on
Historical Performance
AUPH annual EBITDA is up +118.89% over the past 3 years, and up +144.78% over the past 5 years
All-Time High Comparison
AUPH annual EBITDA is currently at its all-time high
3-Year Low Comparison
AUPH annual EBITDA is +130.39% above its 3-year low of -$110.29M reached on an earlier date
Sector Comparison
AUPH annual EBITDA is higher than 82.09% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

AUPH Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$33.52M+146.8%+118.9%+144.8%+560.9%
Quarterly EBITDA$35.54M+67.5%+494.8%+182.8%+3152.9%
TTM EBITDA$116.55M+2944.6%+203.7%+201.6%+3874.3%
Price$15.28+89.3%+74.2%+7.4%
PE Ratio27.23-87.0%
Annual Revenue$235.13M+34.0%+415.6%+10000.0%+6220.1%
Annual EPS$0.04+107.2%+102.8%+104.1%+101.3%
Annual EBIT$14.07M+116.9%+107.8%+118.5%+271.0%
Annual Net Income$5.75M+107.4%+103.2%+106.5%+182.4%

EBITDA Highs

AUPH Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$33.52Mat high
5Y$33.52Mat high
All$33.52Mat high

EBITDA Lows

AUPH Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$110.29MN/A+130.4%
5Y-$177.40M+118.9%
All-$177.40M+118.9%

EBITDA History

YearValueChange
$33.52M+146.8%
-$71.67M+35.0%
-$110.29M+37.8%
-$177.40M-84.6%
-$96.11M-28.4%
-$74.85M-37.1%
-$54.59M-19.7%
-$45.61M-113.8%
-$21.34M+3.1%
-$22.02M-37.6%
-$16.00M-356.4%
-$3.51M+26.8%
-$4.79M+16.2%
-$5.72M-50.8%
YearValueChange
-$3.79M+47.9%
-$7.27M+55.2%
-$16.22M+48.5%
-$31.48M-37.5%
-$22.89M+14.9%
-$26.89M-44.8%
-$18.56M-104.7%
-$9.07M-975.7%
-$843.20K+89.9%
-$8.31M-38.3%
-$6.01M-240.6%
-$1.76M+18.5%
-$2.17M-

FAQ

  • What is the current annual EBITDA of AUPH?

    As of today, AUPH annual EBITDA is $33.52M

  • What is 1-year change in AUPH annual EBITDA?

    AUPH annual EBITDA is up +146.77% year-over-year

  • What is 3-year change in AUPH annual EBITDA?

    AUPH annual EBITDA is up +118.89% over the past 3 years

  • How far is AUPH annual EBITDA from its all-time high?

    AUPH annual EBITDA is currently at its all-time high

  • How does AUPH annual EBITDA rank versus sector peers?

    AUPH annual EBITDA is higher than 82.09% of companies in Healthcare sector

  • When is AUPH next annual earnings release?

    The next annual earnings release for AUPH is on

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. AUPH Official Website www.auriniapharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1600620/000160062025000106/0001600620-25-000106-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1600620/000160062025000011/0001600620-25-000011-index.htm
  4. AUPH Profile on Yahoo Finance finance.yahoo.com/quote/AUPH
  5. AUPH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/auph